Karol Budohoski
Neurological Surgery · Salt Lake City, UTNPI 1679162408
Payments from drug & device makers
What this record shows
The money is spread across several categories — charitable contributions (54.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Mizuho America, Inc. at 54.7% of the total.
Across 64 payments — averaging $461.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mizuho America, Inc.$16K
- Medical Device Business Services, Inc.$12K
- Johnson & Johnson$331
- Medtronic$259
- Stryker$247
- Penumbra, Inc.$153
- plus $440 from 6 others
What the payments were for
- Consulting fees$4,50015%
- Travel & lodging$6,48622%
- Food & beverage$2,3838%
- Gifts$80%
- Charitable contribution$16,15555%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mizuho America, Inc. | 1 | $16,155 |
| Medical Device Business Services, Inc. | 36 | $11,947 |
| Johnson & Johnson | 6 | $331 |
| Medtronic | 2 | $259 |
| Stryker | 9 | $247 |
| Penumbra, Inc. | 2 | $153 |
| Balt USA, LLC | 1 | $149 |
| Phenox Inc. | 1 | $125 |
| Microvention, Inc. | 3 | $82 |
| Route 92 Medical, Inc. | 1 | $51 |
| Qapel Medical Inc | 1 | $19 |
| Cardiva Medical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMBOGUARD$7,500
- TRUFILL$2,763
- Pulsar Vascular PulseRider Aneurysm Neck Reconstruction Device$2,616
- CEREPAK UNIFORM$1,378
- Pipeline$163
- Optima Coil System$149
- Penumbra System$136
- Avenir Coils$125
How this compares
$29,532 in reported general payments places this provider in the 80th percentile of 75 neurological surgery providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prasugrel Hcl | 28 | $4,473 |
| ClopidogrelClopidogrel Bisulfate | 22 | $244 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Salt Lake City
- Mark MahanSalt Lake City$698K
- Ramesh GrandhiSalt Lake City$586K
- Kenneth YonemuraSalt Lake City$117K
- Andrew DaileySalt Lake City$74K
- Craig KilburgSalt Lake City$66K
- Ronald ApfelbaumSalt Lake City$56K
- Guilherme Santos PiedadeSalt Lake City$51K
- Randy JensenSalt Lake City$22K
- Joe MendezSalt Lake City$17K
- Ilyas EliSalt Lake City$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.